Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models

被引：13

作者：

Lai, Honghao ^{[1
,2
]}

Ge, Long ^{[1
,2
,3
]}

Sun, Mingyao ^{[4
]}

Pan, Bei ^{[5
]}

Huang, Jiajie ^{[6
]}

Hou, Liangying ^{[5
,7
]}

Yang, Qiuyu ^{[1
,2
]}

Liu, Jiayi ^{[1
,2
]}

Liu, Jianing ^{[6
]}

Ye, Ziying ^{[1
,2
]}

Xia, Danni ^{[1
,2
]}

Zhao, Weilong ^{[1
,2
]}

Wang, Xiaoman ^{[5
]}

Liu, Ming ^{[5
,7
]}

Talukdar, Jhalok Ronjan ^{[7
]}

Tian, Jinhui ^{[3
,5
]}

Yang, Kehu ^{[3
,5
]}

Estill, Janne ^{[5
,8
]}

机构：

[1] Lanzhou Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Lanzhou, Peoples R China

[2] Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, 199 Donggang West Rd, Lanzhou 730000, Peoples R China

[3] Key Lab Evidence Based Med & Knowledge Translat Ga, Lanzhou, Peoples R China

[4] Lanzhou Univ, Evidence Based Nursing Ctr, Sch Nursing, Lanzhou, Peoples R China

[5] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou, Peoples R China

[6] Gansu Univ Chinese Med, Coll Nursing, Lanzhou, Peoples R China

[7] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

[8] Univ Geneva, Inst Global Hlth, Geneva, Switzerland

来源：

JAMA NETWORK OPEN | 2024年 / 7卷 / 05期

关键词：

DOUBLE-BLIND; PRIMARY INSOMNIA; INTERRATER RELIABILITY; REBOUND INSOMNIA; WEIGHT-LOSS; LONG-TERM; RED MEAT; EFFICACY; SAFETY; DIET;

D O I：

10.1001/jamanetworkopen.2024.12687

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Importance Large language models (LLMs) may facilitate the labor-intensive process of systematic reviews. However, the exact methods and reliability remain uncertain. Objective To explore the feasibility and reliability of using LLMs to assess risk of bias (ROB) in randomized clinical trials (RCTs). Design, Setting, and Participants A survey study was conducted between August 10, 2023, and October 30, 2023. Thirty RCTs were selected from published systematic reviews. Main Outcomes and Measures A structured prompt was developed to guide ChatGPT (LLM 1) and Claude (LLM 2) in assessing the ROB in these RCTs using a modified version of the Cochrane ROB tool developed by the CLARITY group at McMaster University. Each RCT was assessed twice by both models, and the results were documented. The results were compared with an assessment by 3 experts, which was considered a criterion standard. Correct assessment rates, sensitivity, specificity, and F1 scores were calculated to reflect accuracy, both overall and for each domain of the Cochrane ROB tool; consistent assessment rates and Cohen kappa were calculated to gauge consistency; and assessment time was calculated to measure efficiency. Performance between the 2 models was compared using risk differences. Results Both models demonstrated high correct assessment rates. LLM 1 reached a mean correct assessment rate of 84.5% (95% CI, 81.5%-87.3%), and LLM 2 reached a significantly higher rate of 89.5% (95% CI, 87.0%-91.8%). The risk difference between the 2 models was 0.05 (95% CI, 0.01-0.09). In most domains, domain-specific correct rates were around 80% to 90%; however, sensitivity below 0.80 was observed in domains 1 (random sequence generation), 2 (allocation concealment), and 6 (other concerns). Domains 4 (missing outcome data), 5 (selective outcome reporting), and 6 had F1 scores below 0.50. The consistent rates between the 2 assessments were 84.0% for LLM 1 and 87.3% for LLM 2. LLM 1's kappa exceeded 0.80 in 7 and LLM 2's in 8 domains. The mean (SD) time needed for assessment was 77 (16) seconds for LLM 1 and 53 (12) seconds for LLM 2. Conclusions In this survey study of applying LLMs for ROB assessment, LLM 1 and LLM 2 demonstrated substantial accuracy and consistency in evaluating RCTs, suggesting their potential as supportive tools in systematic review processes.

引用

页数：12